XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Goodwill and Other Intangible Assets
 3 Months Ended
Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets GOODWILL AND OTHER INTANGIBLE ASSETS
 
Changes in the carrying amount of acquired intangible assets during the three months ended March 31, 2019 are summarized as follows (in millions):
 
Trademarks and
Tradenames
 
Customer
Relationships
 
Patents and
Technology
 
Land Use Rights
 
Total
Gross carrying amounts:
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2018
$
203.4

 
$
586.3

 
$
155.8

 
$
8.6

 
$
954.1

Foreign currency translation
(0.9
)
 
(1.2
)
 
(1.4
)
 
0.2

 
(3.3
)
Balance as of March 31, 2019
$
202.5

 
$
585.1

 
$
154.4

 
$
8.8

 
$
950.8


 
Trademarks and
Tradenames
 
Customer
Relationships
 
Patents and
Technology
 
Land Use Rights
 
Total
Accumulated amortization:
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2018
$
73.4

 
$
310.8

 
$
80.7

 
$
3.0

 
$
467.9

Amortization expense
2.8

 
10.0

 
2.5

 
—

 
15.3

Foreign currency translation
—

 
(0.5
)
 
(0.9
)
 
0.1

 
(1.3
)
Balance as of March 31, 2019
$
76.2

 
$
320.3

 
$
82.3

 
$
3.1

 
$
481.9


 
Trademarks and
Tradenames
Indefinite-lived intangible assets:
 
Balance as of December 31, 2018
$
86.9

Foreign currency translation
(0.5
)
Balance as of March 31, 2019
$
86.4


The Company currently amortizes certain acquired intangible assets, primarily on a straight-line basis, over their estimated useful lives, which range from three to 50 years.
        
Changes in the carrying amount of goodwill during the three months ended March 31, 2019 are summarized as follows (in millions):
 
North
America
 
South
America
 
Europe/Middle East
 
Asia/Pacific/Africa
 
Consolidated
Balance as of December 31, 2018
$
611.1

 
$
116.7

 
$
649.6

 
$
118.1

 
$
1,495.5

Foreign currency translation
—

 
(0.5
)
 
(9.5
)
 
0.1

 
(9.9
)
Balance as of March 31, 2019
$
611.1

 
$
116.2

 
$
640.1

 
$
118.2

 
$
1,485.6



Goodwill is tested for impairment on an annual basis and more often if indications of impairment exist. The Company conducts its annual impairment analyses as of October 1 each fiscal year. There have been no indicators of impairment during the three months ended March 31, 2019.